Fujifilm SonoSite S-Nerve™ Ultrasound System Singapour - anglais - HSA (Health Sciences Authority)

fujifilm sonosite s-nerve™ ultrasound system

bluestone corporation pte ltd - radiology / imaging - the sonosite s-nerve ultrasound systems are a general purpose ultrasound system intended for use by a qualified physician for evaluation by ultrasound imaging or fluid flow analysis of the human body. specific clinical applications and exam types include: ophthalmic, fetal, abdominal, intra-operative (abdominal organs and vascular), intra-operative (neuro.), pediatric, small organ (breast, thyroid, testicles. prostate), neonatal cephalic, adult cephalic, musculo-.skeletal (conventional); musculo-skeletal (superficial); cardiac adult, cardiac pediatric, peripheral vessel

CURODONT REPAIR FLUORIDE PLUS- sodium fluoride sponge États-Unis - anglais - NLM (National Library of Medicine)

curodont repair fluoride plus- sodium fluoride sponge

credentis ag - sodium fluoride 0.05%, (0.02% w/v fluoride ion) - anticavity aids in the prevention of dental cavities - anticavity dental rinse - restores enamel - for the treatment of white spots

CURODONT PROTECT- stannous fluoride paste, dentifrice États-Unis - anglais - NLM (National Library of Medicine)

curodont protect- stannous fluoride paste, dentifrice

credentis ag - stannous fluoride 0.454%, (0.14% w/v fluoride ion) - anticavity and antisensitivity - aids in the prevention of dental cavities and builds increasing protection against painful sensitivity of the teeth.

MYZILRA- levonorgestrel and ethinyl estradiol États-Unis - anglais - NLM (National Library of Medicine)

myzilra- levonorgestrel and ethinyl estradiol

par pharmaceutical - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - levonorgestrel 0.05 mg - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use myzilra® tablets as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. depending on method (calendar, ovulation, symptothermal, post-ovulation) adapted from hatcher ra et al, contraceptive technology: 17th revised edition. ny, ny: ardent media, inc., 1998. oral contraceptives should not be used in women with any of the following conditions: thrombophlebitis or thromboembolic disorders. a past history of deep-vein thrombophlebitis or thromboembolic disorders. cerebral-vascular or coronary-artery disease. known or suspected carcinoma of the breast. carcinoma of

Chateal® (Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg) États-Unis - anglais - NLM (National Library of Medicine)

chateal® (levonorgestrel and ethinyl estradiol tablets, usp 0.15 mg/0.03 mg)

rpk pharmaceuticals, inc. - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. na - not available a depending on method (calendar, ovulation, symptothermal, post-ovulation) adapted from hatcher ra et al, contraceptive technology : 17th revised edition . ny, ny: ardent media, inc., 1998. combination oral contraceptives should not be used in women with any of the following conditions: thrombophlebitis or thromboembolic disorders. a past history of deep-vein thrombophlebitis or thromboembolic disorders. cerebral-vascular or coronary-artery disease. thrombogenic valvulopathies

LEVONORGESTREL AND ETHINYL ESTRADIOL- levonorgestrel and ethinyl estradiol tablets États-Unis - anglais - NLM (National Library of Medicine)

levonorgestrel and ethinyl estradiol- levonorgestrel and ethinyl estradiol tablets

xiromed, llc. - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.   oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates.   table ii: percentage of women experiencing an unintended pregnancy during the first year of use of a contraceptive method na – not available   *depending on method (calendar, ovulation, symptothermal, post-ovulation) adapted from hatcher ra et al, contraceptive technology: 17th revised edition . ny, ny: ardent media, inc., 1998 combination oral contraceptives should not be used in women with any of the following conditions:   thrombophlebitis or thromboembolic disorders.   a past history of deep

LEVONORGESTREL AND ETHINYL ESTRADIOL-  levonorgestrel and ethinyl estradiol  kit États-Unis - anglais - NLM (National Library of Medicine)

levonorgestrel and ethinyl estradiol- levonorgestrel and ethinyl estradiol kit

lupin pharmaceuticals, inc. - ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u), levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw) - ethinyl estradiol 0.03 mg - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. na - not available combination oral contraceptives should not be used in women with any of the following conditions: thrombophlebitis or thromboembolic disorders. a past history of deep-vein thrombophlebitis or thromboembolic disorders. cerebral-vascular or coronary-artery disease. thrombogenic valvulopathies. thrombogenic rhythm disorders. diabetes with vascular involvement. uncontrolled hypertension. known or suspected carcinoma of the breast. carcinoma of the endometrium or other known or suspecte

LEVONORGESTREL AND ETHINYL ESTRADIOL-  levonorgestrel and ethinyl estradiol  kit États-Unis - anglais - NLM (National Library of Medicine)

levonorgestrel and ethinyl estradiol- levonorgestrel and ethinyl estradiol kit

lupin limited - ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u), levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw) - ethinyl estradiol 0.03 mg - oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization and the iud, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. na - not available combination oral contraceptives should not be used in women with any of the following conditions: thrombophlebitis or thromboembolic disorders. a past history of deep-vein thrombophlebitis or thromboembolic disorders. cerebral-vascular or coronary-artery disease. thrombogenic valvulopathies. thrombogenic rhythm disorders. diabetes with vascular involvement. uncontrolled hypertension. known or suspected carcinoma of the breast. carcinoma of the endometrium or other known or suspecte

Information system software, application program, patient record Australie - anglais - Department of Health (Therapeutic Goods Administration)

information system software, application program, patient record

nico.lab international limited - 44106 - information system software, application program, patient record - strokeviewer is a service image software processing application that analyses stroke imaging data. from the analysis a report is compiled containing visualization of stroke-relevant imaging properties that can assist a physician in diagnosis of stroke. strokeviewer is used by a physician, or a person working under the supervision of a physician, at radiological or emergency departments. strokeviewer is intended to be used in assisting the diagnosis of all patients with (acute) neurological deficit due to (suspected) stroke. strokeviewer is not intended to be used in diagnosis decision support; the direct diagnosis is decided upon by the physician. strokeviewer is a fully automated application executed in a remote cloud based environment, and operates in a complete secure environment. received dicom images are automatically analysed, and an analysis report is transferred back. furthermore, a dicom webviewer is enabled for the user with credentials, to view the analysed data.

EMZAHH- norethindrone tablet États-Unis - anglais - NLM (National Library of Medicine)

emzahh- norethindrone tablet

aurobindo pharma limited - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s) - 1.       indications  progestin-only oral contraceptives are indicated for the prevention of pregnancy.  2.      efficacy if used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.3%. however, the typical failure rate is estimated to be closer to 9%, due to late or omitted pills. table 1 lists the pregnancy rates for users of all major methods of contraception. emergency contraception: emergency contraceptive pills or insertion of a copper intrauterine contraceptive after unprotected intercourse substantially reduces the risk of pregnancy.9 (see chapter 6.). lactational amenorrhea method: lam is a highly effective, temporary method of contraception.10 (see chapter 18.) source: trussell j. contraceptive efficacy. in hatcher ra, trussell j, nelson al, cates w, kowal d, policar m. contraceptive techology: twentieth revised edition. new york ny: ardent media, 2011. ——————————————————————————————————————————————————————————————————— notes: 1       among typical couples who initia